Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Local Drug Makers Urge Bangladesh To Slow Allowing Newcomer Makers

This article was originally published in PharmAsia News

Executive Summary

Bangladesh's pharmaceutical industry reports as many as 20 new companies have been registered to operate in the country in recent years, possibly attracting more than $146 million in investments, according to some estimates. Industry leaders note, however, the local drug market would not be able to absorb that much investment. The same leaders said any companies that entered the market within the past five years would not reach a healthy position soon. They urged the government to concentrate less on registering newcomers and focus on ensuring drug quality. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel